| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |